6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,298 / 薬物数 : 2,202 - (DrugBank : 350) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 202

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03205488 (ClinicalTrials.gov)	October 16, 2017	28/6/2017	Nilotinib in Parkinson's Disease	A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Defin ...	Parkinson Disease	Drug: Cohort 1:NilotinibOral Capsules (150mg or 300mg);Drug: Cohort 2: NilotinibOral Capsules (dose ...	Northwestern University	University of Rochester;University of Iowa;Michael J. Fox Foundation for Parkinson's Research	Completed	40 Years	79 Years	All	76	Phase 2	United States
2	NCT02954978 (ClinicalTrials.gov)	January 2017	1/11/2016	Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease	A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Impact of Low Doses of Nilotini ...	Parkinson Disease;Parkinsons Disease With Dementia	Drug: Placebo Oral Capsule;Drug: Nilotinib 150mg oral capsule [Tasigna];Drug: Nilotinib 300mg oral cap ...	Georgetown University	NULL	Active, not recruiting	40 Years	90 Years	All	75	Phase 2	United States
3	NCT02281474 (ClinicalTrials.gov)	November 2014	27/10/2014	Nilotinib in Cognitively Impaired Parkinson Disease Patients 001	Open Label Dose Escalation of Nilotinibin Cognitively Impaired Parkinson Disease Patients With Eleva ...	Parkinson's Disease;Parkinson's Disease Dementia;Diffuse Lewy Body Disease	Drug: Nilotinib	Georgetown University	NULL	Completed	40 Years	90 Years	Both	12	Phase 1	United States

First Previous1Next Last